CoChat
Sign Up
Cited by 21

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Blood Cell MicroRNAs: What Are They and What Future Do They Hold?

Ryan, Patricia, Atreya, Chintamani·2011·Transfusion Medicine Reviews
DOI 10.1016/j.tmrv.2011.01.005
Open this paper in CoChat — free account

Abstract

The advent of blood component storage revolutionized health care by allowing for a managed supply of transfusion quality blood products. During storage, blood components undergo a series of physiological changes that affect the product quality, which ultimately can interfere with the safety and efficacy of such products after transfusion. Despite continuous improvements in blood component quality and safety, it is still desirable to have in vitro standard markers of measurable characteristics that predict blood component safety and efficacy in vivo following their transfusion. Over the last decade, research on the feasibility of using microRNAs as biomarkers for various clinical manifestations and cellular pathologies has exploded. Here, we review the literature on blood cell microRNAs and discuss the potential of these molecules to act as measurable characteristics (product biomarkers) for stored blood component quality and safety.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.tmrv.2011.01.005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 38

  1. Bartel, 2004, MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  2. Griffiths-Jones, 2008, miRBase: Tools for microRNA genomics, Nucleic Acids Res, 36, D154, 10.1093/nar/gkm952 · DOI
  3. Calin, 2008, MiR-15a and miR-16-1 cluster functions in human leukemia, Proc Natl Acad Sci U S A, 105, 5166, 10.1073/pnas.0800121105 · DOI
  4. Vatolin, 2006, A novel method to detect functional microRNA targets, J Mol Biol, 358, 983, 10.1016/j.jmb.2006.02.063 · DOI
  5. Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res, 19, 92, 10.1101/gr.082701.108 · DOI · Paper page
  6. Denli, 2004, Processing of primary microRNAs by the microprocessor complex, Nature, 432, 231, 10.1038/nature03049 · DOI · Paper page
  7. Gregory, 2004, The microprocessor complex mediates the genesis of microRNAs, Nature, 432, 235, 10.1038/nature03120 · DOI
  8. Lee, 2003, The nuclear RNase III Drosha initiates microRNA processing, Nature, 425, 415, 10.1038/nature01957 · DOI
  9. Provost, 2002, Ribonuclease activity and RNA binding of recombinant human Dicer, EMBO J, 21, 5864, 10.1093/emboj/cdf578 · DOI
  10. Chendrimada, 2005, TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing, Nature, 436, 740, 10.1038/nature03868 · DOI
  11. Liu, 2004, Argonaute2 is the catalytic engine of mammalian RNAi, Science, 305, 1437, 10.1126/science.1102513 · DOI · Paper page
  12. De, 2010, MicroRNAs as biomarkers for CNS cancer and other disorders, Brain Res, 1338, 100, 10.1016/j.brainres.2010.03.103 · DOI
  13. Li, 2010, Review: The role of microRNAs in kidney disease, Nephrology (Carlton), 15, 599, 10.1111/j.1440-1797.2010.01363.x · DOI
  14. Buckland, 2010, Biomarkers: Micrornas under the spotlight in inflammatory arthritis, Nat Rev Rheumatol, 6, 436, 10.1038/nrrheum.2010.112 · DOI
  15. Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634 · DOI
  16. Bloomston, 2007, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, JAMA, 297, 1901, 10.1001/jama.297.17.1901 · DOI · Paper page
  17. Chan, 2008, miR-21 microRNA expression in human gastric carcinomas and its clinical association, Anticancer Res, 28, 907
  18. Lawrie, 2008, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, Br J Haematol, 141, 672, 10.1111/j.1365-2141.2008.07077.x · DOI
  19. Kulkarni, 2010, Omic approaches to quality biomarkers for stored platelets: Are we there yet?, Transfus Med Rev, 24, 211, 10.1016/j.tmrv.2010.03.003 · DOI
  20. D'Alessandro, 2010, Red blood cell storage: The story so far, Blood Transfus, 8, 82
  21. Solheim, 2004, Clinical implications of red blood cell and platelet storage lesions: An overview, Transfus Apher Sci, 31, 185, 10.1016/j.transci.2004.09.004 · DOI
  22. Gnatenko, 2003, Transcript profiling of human platelets using microarray and serial analysis of gene expression, Blood, 101, 2285, 10.1182/blood-2002-09-2797 · DOI
  23. Hamilton, 2010, MicroRNA in erythrocytes, Biochem Soc Trans, 38, 229, 10.1042/BST0380229 · DOI · Paper page
  24. Warshaw, 1967, Protein synthesis by human platelets, J Biol Chem, 242, 2094, 10.1016/S0021-9258(18)96021-7 · DOI
  25. Weyrich, 2009, Protein synthesis by platelets: Historical and new perspectives, J Thromb Haemost, 7, 241, 10.1111/j.1538-7836.2008.03211.x · DOI
  26. Landry, 2009, Existence of a microRNA pathway in anucleate platelets, Nat Struct Mol Biol, 16, 961, 10.1038/nsmb.1651 · DOI
  27. Kannan, 2009, Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis, Transfusion, 49, 1443, 10.1111/j.1537-2995.2009.02140.x · DOI
  28. Kondkar, 2010, VAMP8/endobrevin is overexpressed in hyperreactive human platelets: Suggested role for platelet microRNA, J Thromb Haemost, 8, 369, 10.1111/j.1538-7836.2009.03700.x · DOI
  29. Peter, 2002, Red blood cells, Int J Biochem Cell Biol, 34, 1513, 10.1016/S1357-2725(02)00087-0 · DOI
  30. Chen, 2008, The genomic analysis of erythrocyte microRNA expression in sickle cell diseases, PLoS One, e2360, 3
  31. Rathjen, 2006, Analysis of short RNAs in the malaria parasite and its red blood cell host, FEBS Lett, 580, 5185, 10.1016/j.febslet.2006.08.063 · DOI · Paper page
  32. Kannan, 2010, Differential profiling of human red blood cells during storage for 52 selected microRNAs, Transfusion, 50, 1581, 10.1111/j.1537-2995.2010.02585.x · DOI · Paper page
  33. Bratosin, 2001, Programmed cell death in mature erythrocytes: A model for investigating death effector pathways operating in the absence of mitochondria, Cell Death Differ, 8, 1143, 10.1038/sj.cdd.4400946 · DOI
  34. Zhang, 2010, Plasma MicroRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases, Clin Chem, 56, 1820, 10.1373/clinchem.2010.147850 · DOI · Paper page
  35. Fehri, 2009, Helicobacter pylori-induced modification of the histone H3 phosphorylation status in gastric epithelial cells reflects its impact on cell cycle regulation, Epigenetics, 4, 577, 10.4161/epi.4.8.10217 · DOI
  36. Marquez, 2010, Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans, Lab Invest, 90, 1727, 10.1038/labinvest.2010.126 · DOI
  37. Krol, 2010, The widespread regulation of microRNA biogenesis, function and decay, Nat Rev Genet, 11, 597, 10.1038/nrg2843 · DOI · Paper page
  38. Wang, 2009, Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins, Nat Struct Mol Biol, 16, 1259, 10.1038/nsmb.1712 · DOI

Cited by

Sorted by citations

See all 21

Metadata

Authors
Ryan, P., & Atreya, C.
Venue
Transfusion Medicine Reviews
Publisher
Elsevier BV
Published
2011-07
Volume
25
Issue
3
Pages
247-251
ISSN
0887-7963
DOI
10.1016/j.tmrv.2011.01.005
Cited by
21
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review